Suppr超能文献

重塑肿瘤物理微环境以改善药物递送与疗效:从数学建模到实验台再到临床应用

Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.

作者信息

Stylianopoulos Triantafyllos, Munn Lance L, Jain Rakesh K

机构信息

Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, 1678, Cyprus.

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Trends Cancer. 2018 Apr;4(4):292-319. doi: 10.1016/j.trecan.2018.02.005. Epub 2018 Mar 13.

Abstract

Physical forces have a crucial role in tumor progression and cancer treatment. The application of principles of engineering and physical sciences to oncology has provided powerful insights into the mechanisms by which these forces affect tumor progression and confer resistance to delivery and efficacy of molecular, nano-, cellular, and immuno-medicines. Here, we discuss the mechanics of the solid and fluid components of a tumor, with a focus on how they impede the transport of therapeutic agents and create an abnormal tumor microenvironment (TME) that fuels tumor progression and treatment resistance. We also present strategies to reengineer the TME by normalizing the tumor vasculature and the extracellular matrix (ECM) to improve cancer treatment. Finally, we summarize various mathematical models that have provided insights into the physical barriers to cancer treatment and revealed new strategies to overcome these barriers.

摘要

物理力在肿瘤进展和癌症治疗中起着关键作用。将工程学和物理科学原理应用于肿瘤学,为理解这些力影响肿瘤进展以及赋予分子、纳米、细胞和免疫药物递送及疗效抗性的机制提供了有力的见解。在此,我们讨论肿瘤固体和流体成分的力学,重点关注它们如何阻碍治疗剂的运输,并创造一个促进肿瘤进展和治疗抗性的异常肿瘤微环境(TME)。我们还提出了通过使肿瘤血管系统和细胞外基质(ECM)正常化来重新构建TME以改善癌症治疗的策略。最后,我们总结了各种数学模型,这些模型为癌症治疗的物理障碍提供了见解,并揭示了克服这些障碍的新策略。

相似文献

2
Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
Trends Cancer. 2018 Apr;4(4):258-259. doi: 10.1016/j.trecan.2018.02.010. Epub 2018 Mar 17.
3
Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Trends Cancer. 2018 Apr;4(4):268-271. doi: 10.1016/j.trecan.2018.02.006. Epub 2018 Mar 12.
4
Physical oncology: New targets for nanomedicine.
Biomaterials. 2018 Jan;150:87-99. doi: 10.1016/j.biomaterials.2017.10.014. Epub 2017 Oct 6.
6
Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Adv Drug Deliv Rev. 2021 May;172:80-103. doi: 10.1016/j.addr.2021.02.019. Epub 2021 Mar 9.
7
Boosting antitumor efficacy of nanoparticles by modulating tumor mechanical microenvironment.
EBioMedicine. 2024 Jul;105:105200. doi: 10.1016/j.ebiom.2024.105200. Epub 2024 Jun 13.
8
Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Med Res Rev. 2020 May;40(3):1084-1102. doi: 10.1002/med.21644. Epub 2019 Nov 11.
9
Transport Barriers and Oncophysics in Cancer Treatment.
Trends Cancer. 2018 Apr;4(4):277-280. doi: 10.1016/j.trecan.2018.02.008. Epub 2018 Mar 15.
10
Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
J Nanobiotechnology. 2021 Nov 22;19(1):384. doi: 10.1186/s12951-021-01134-6.

引用本文的文献

1
Synergistic mechanotherapy and sonopermeation guided by mathematical modeling for solid tumor treatment.
Front Drug Deliv. 2025 Jun 24;5:1549098. doi: 10.3389/fddev.2025.1549098. eCollection 2025.
2
Gene editing for collagen disorders: current advances and future perspectives.
Gene Ther. 2025 Aug 11. doi: 10.1038/s41434-025-00560-7.
3
Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming.
Front Pharmacol. 2025 Jul 7;16:1634413. doi: 10.3389/fphar.2025.1634413. eCollection 2025.
5
Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor microenvironment to improve treatment efficacy.
PLoS One. 2025 Jul 11;20(7):e0328196. doi: 10.1371/journal.pone.0328196. eCollection 2025.
6
An overview of the feasibility of nanomedicine in pancreatic cancer theranostics.
Explor Target Antitumor Ther. 2025 Jun 18;6:1002326. doi: 10.37349/etat.2025.1002326. eCollection 2025.
7
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer.
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2500019122. doi: 10.1073/pnas.2500019122. Epub 2025 Jun 11.
8
Matrix stiffness-driven cancer progression and the targeted therapeutic strategy.
Mechanobiol Med. 2023 Aug 3;1(2):100013. doi: 10.1016/j.mbm.2023.100013. eCollection 2023 Dec.
9
The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness.
NPJ Biol Phys Mech. 2025;2(1):13. doi: 10.1038/s44341-025-00017-3. Epub 2025 May 5.
10
Desmoplastic tumor priming using clinical-stage corticosteroid liposomes.
Cell Biomater. 2025 Apr 22;1(3):None. doi: 10.1016/j.celbio.2025.100051.

本文引用的文献

1
Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
PLoS One. 2018 Mar 21;13(3):e0193801. doi: 10.1371/journal.pone.0193801. eCollection 2018.
2
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
Nat Rev Clin Oncol. 2018 May;15(5):325-340. doi: 10.1038/nrclinonc.2018.29. Epub 2018 Mar 6.
3
Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration.
Ann Biomed Eng. 2018 May;46(5):657-669. doi: 10.1007/s10439-018-1997-7. Epub 2018 Feb 22.
4
Nanoparticle elasticity directs tumor uptake.
Nat Commun. 2018 Jan 9;9(1):130. doi: 10.1038/s41467-017-02588-9.
5
Immunotherapy: Gut bacteria modulate responses to PD-1 blockade.
Nat Rev Clin Oncol. 2018 Jan;15(1):6-7. doi: 10.1038/nrclinonc.2017.182. Epub 2017 Nov 21.
6
EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling.
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10532-E10539. doi: 10.1073/pnas.1711534114. Epub 2017 Nov 20.
7
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy.
Nature. 2017 Nov 23;551(7681):517-520. doi: 10.1038/nature24473. Epub 2017 Nov 8.
8
Transport of drugs from blood vessels to tumour tissue.
Nat Rev Cancer. 2017 Dec;17(12):738-750. doi: 10.1038/nrc.2017.93. Epub 2017 Nov 10.
9
Tissue Force Programs Cell Fate and Tumor Aggression.
Cancer Discov. 2017 Nov;7(11):1224-1237. doi: 10.1158/2159-8290.CD-16-0733. Epub 2017 Oct 16.
10
Engineering and physical sciences in oncology: challenges and opportunities.
Nat Rev Cancer. 2017 Nov;17(11):659-675. doi: 10.1038/nrc.2017.83. Epub 2017 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验